These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors. Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203 [TBL] [Abstract][Full Text] [Related]
3. Current development of lentiviral-mediated gene transfer. Romano G Drug News Perspect; 2005 Mar; 18(2):128-34. PubMed ID: 15883621 [TBL] [Abstract][Full Text] [Related]
4. Lentiviral vectors for use in the central nervous system. Jakobsson J; Lundberg C Mol Ther; 2006 Mar; 13(3):484-93. PubMed ID: 16403676 [TBL] [Abstract][Full Text] [Related]
5. Lentiviral vectors for treating and modeling human CNS disorders. Azzouz M; Kingsman SM; Mazarakis ND J Gene Med; 2004 Sep; 6(9):951-62. PubMed ID: 15352068 [TBL] [Abstract][Full Text] [Related]
6. Lentiviral vectors for gene therapy of heart disease. Higuchi K; Medin JA J Cardiol; 2007 Jan; 49(1):1-11. PubMed ID: 17269208 [TBL] [Abstract][Full Text] [Related]
7. Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. Vigna E; Naldini L J Gene Med; 2000; 2(5):308-16. PubMed ID: 11045424 [TBL] [Abstract][Full Text] [Related]
8. Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics. Breckpot K; Aerts JL; Thielemans K Gene Ther; 2007 Jun; 14(11):847-62. PubMed ID: 17361214 [TBL] [Abstract][Full Text] [Related]
10. Gene therapy for neurodegenerative diseases based on lentiviral vectors. Nanou A; Azzouz M Prog Brain Res; 2009; 175():187-200. PubMed ID: 19660657 [TBL] [Abstract][Full Text] [Related]
11. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector. Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055 [TBL] [Abstract][Full Text] [Related]
12. Cancer cells as targets for lentivirus-mediated gene transfer and gene therapy. Pellinen R; Hakkarainen T; Wahlfors T; Tulimäki K; Ketola A; Tenhunen A; Salonen T; Wahlfors J Int J Oncol; 2004 Dec; 25(6):1753-62. PubMed ID: 15547714 [TBL] [Abstract][Full Text] [Related]
13. FIV: from lentivirus to lentivector. Saenz DT; Poeschla EM J Gene Med; 2004 Feb; 6 Suppl 1():S95-104. PubMed ID: 14978754 [TBL] [Abstract][Full Text] [Related]
14. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies. Van Damme A; Chuah MK; Collen D; VandenDriessche T Semin Thromb Hemost; 2004 Apr; 30(2):185-95. PubMed ID: 15118930 [TBL] [Abstract][Full Text] [Related]
16. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production. Sinn PL; Sauter SL; McCray PB Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340 [TBL] [Abstract][Full Text] [Related]
17. Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors. McKay T; Patel M; Pickles RJ; Johnson LG; Olsen JC Gene Ther; 2006 Apr; 13(8):715-24. PubMed ID: 16397505 [TBL] [Abstract][Full Text] [Related]
18. Shuttle of lentiviral vectors via transplanted cells in vivo. Blömer U; Gruh I; Witschel H; Haverich A; Martin U Gene Ther; 2005 Jan; 12(1):67-74. PubMed ID: 15385952 [TBL] [Abstract][Full Text] [Related]
19. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer. Blesch A Methods; 2004 Jun; 33(2):164-72. PubMed ID: 15121171 [TBL] [Abstract][Full Text] [Related]